Glutamate transporter type 3 mediates isoflurane preconditioning-induced acute phase of neuroprotection in mice

Brain Research Bulletin

Volumn 98, Issue , 2013, Pages 23-29

  Li, Liaoliao ^a   Deng, Jiao ^a,b   Zuo, Zhiyi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Glutamate transporter; Isoflurane; Neuroprotection; Preconditioning

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMATE TRANSPORTER TYPE 3; GLYCOGEN SYNTHASE KINASE 3BETA; ISOFLURANE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR COORDINATION; MOUSE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

AKT; EAAT; ERK1/2; EXCITATORY AMINO ACID TRANSPORTER; EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2; GAPDH; GLUTAMATE TRANSPORTER; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3Β; GSK3Β; ISOFLURANE; MCAO; MIDDLE CEREBRAL ARTERIAL OCCLUSION; NEUROPROTECTION; PRECONDITIONING; PULSE OXIMETER OXYGEN SATURATION; SPO(2);

ANIMALS; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; EXCITATORY AMINO ACID TRANSPORTER 3; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISOFLURANE; MALE; MICE; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION;

EID: 84881238953     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.06.005     Document Type: Article

References (28)

1. Abe K., Saito H. Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes. Journal of Neurochemistry 2001, 76:216-224.
2. Cao L., Feng C., Li L., Zuo Z. Contribution of microRNA-203 to the isoflurane preconditioning-induced neuroprotection. Brain Research Bulletin 2012, 88:525-528.
3. Danbolt N.C. Glutamate uptake. Progress in Neurobiology 2001, 65:1-105.
4. Ding J., Ning B., Huang Y., Zhang D., Li J., Chen C.Y., Huang C. PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells. Current Cancer Drug Targets 2009, 9:500-509.
5. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends in Neurosciences 2003, 26:248-254.
6. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Current Opinion in Cell Biology 1998, 10:262-267.
7. Fang H., Huang Y., Zuo Z. The different responses of rat glutamate transporter type 2 and its mutant (tyrosine 403 to histidine) activity to volatile anesthetics and activation of protein kinase C. Brain Research 2002, 953:255-264.
8. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nature Reviews Neuroscience 2006, 7:437-448.
9. Huang Y., Feng X., Sando J.J., Zuo Z. Critical role of serine 465 in isoflurane-induced increase of cell-surface redistribution and activity of glutamate transporter type 3. Journal of Biological Chemistry 2006, 281:38133-38138.
10. Huang Y., Zuo Z. Isoflurane induces a protein kinase C alpha-dependent increase in cell surface protein level and activity of glutamate transporter type 3. Molecular Pharmacology 2005, 67:1522-1533.
11. Irving E.A., Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. Journal of Cerebral Blood Flow & Metabolism 2002, 22:631-647.
12. Juhaszova M., Zorov D.B., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Role of glycogen synthase kinase-3beta in cardioprotection. Circulation Research 2009, 104:1240-1252.
13. Kapinya K.J., Lowl D., Futterer C., Maurer M., Waschke K., Isaev N.K., Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002, 33:1889-1898.
14. Kotani N., Akaike N. The effects of volatile anesthetics on synaptic and extrasynaptic GABA-induced neurotransmission. Brain Research Bulletin 2013, 93:69-79.
15. Lee S.A., Choi J.G., Zuo Z. Volatile anesthetics attenuate oxidative stress-reduced activity of glutamate transporter type 3. Anesthesia and Analgesia 2009, 109:1506-1510.
16. Li H., Yin J., Li L., Deng J., Feng C., Zuo Z. Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiology of Disease 2013, 54:216-224.
17. Li L., Zuo Z. Glutamate transporter type 3 knockout reduces brain tolerance to focal brain ischemia in mice. Journal of Cerebral Blood Flow & Metabolism 2011, 31:1283-1292.
18. Li L., Zuo Z. Isoflurane postconditioning induces neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability. Neuroscience 2011, 199:44-50.
19. Lin D., Li G., Zuo Z. Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3beta in human neuron-like cells. Neuroscience 2011, 179:73-79.
20. Peghini P., Janzen J., Stoffel W. Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO Journal 1997, 16:3822-3832.
21. Rogers D.C., Campbell C.A., Stretton J.L., Mackay K.B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997, 28:2060-2065.
22. Wang C., Lee J., Jung H., Zuo Z. Pretreatment with volatile anesthetics but not with the nonimmobilizer 1,2-dichlorohexafluorocyclobutane, reduced cell injury in rat cerebellar slices after an in vitro simulated ischemia. Brain Research 2007, 1152:201-208.
23. Wick A., Wick W., Waltenberger J., Weller M., Dichgans J., Schulz J.B. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. Journal of Neuroscience 2002, 22:6401-6407.
24. Yin X.H., Zhang Q.G., Miao B., Zhang G.Y. Neuroprotective effects of preconditioning ischaemia on ischaemic brain injury through inhibition of mixed-lineage kinase 3 via NMDA receptor-mediated Akt1 activation. Journal of Neurochemistry 2005, 93:1021-1029.
25. Zheng S., Zuo Z. Isoflurane preconditioning reduces Purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003, 118:99-106.
26. Zheng S., Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of p38 mitogen-activated protein kinase. Molecular Pharmacology 2004, 65:1172-1180.
27. Zhuang Z.Y., Xu H., Clapham D.E., Ji R.R. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. Journal of Neuroscience 2004, 24:8300-8309.
28. Zuo Z. Are volatile anesthetics neuroprotective or neurotoxic?. Medical Gas Research 2012, 2:10.